fbpx
Home > Events > MOH Workshop for Research & Implementation of Pharmacogenomics

MOH Workshop on Pharmacogenomics Research & Implementation

National Institutes of Health (NIH), Setia Alam

Pharmacogenomics is the scientific study of how a person’s genetic makeup affects their drug response. It combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to understand how genetic variations influence the effectiveness and safety of medications for each individual. Because people have genetic differences, the same drug can work well for one person but be ineffective or cause adverse reactions in another. Pharmacogenomics aims to use genetic information to predict who will benefit from a medication, who will not respond, and who is at risk for side effects. This helps healthcare providers prescribe the right drug at the right dose for each patient, moving away from the traditional “one-size-fits-all” approach to a more personalized treatment strategy.
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics with Global Precision Diagnostics
The field involves analyzing genetic variants, such as single nucleotide polymorphisms (SNPs), that affect drug metabolism, efficacy, and toxicity. Pharmacogenomics supports the development of tailored drugs and dosage recommendations to maximize therapeutic effects while minimizing adverse drug reactions. It is a key component of precision medicine, personalizing healthcare based on genes, environment, and lifestyle. Currently, pharmacogenomics is used in some areas like cancer treatment, HIV therapy, depression, and heart disease, and it is rapidly advancing with ongoing research and clinical trials to expand its applications.

We are proud to have successfully concluded the Workshop for Research & Implementation of Pharmacogenomics (PGx) in Malaysia, a collaborative initiative by the Institute for Medical Research (IMR), and the Precision Medicine & Scientific Wellness Association (PMedS). Our sincere thanks for the valuable work, contributions, and thoughtful discussions that shaped the event go to;

  • Datuk Dr. Nor Fariza Binti Ngah, Deputy Director-General of Health (Research & Technical Support), for her inspiring foreword and continued support
  • Dr. Ami Fazlin Binti Syed Mohamed, Director of IMR
  • Dr. Adiratna Mat Ripen, Head of the Cancer Research Centre (CaRC), IMR & Head of Precision Medicine Research Cluster, NIH
  • Professor Prof. Dr. Tan Geok Chin, PMedS President

Implementing of Pharmacogenomics

Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics with Dr Rebecca
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics

The pictures shown above were taken during the workshop. They introduce some vital topics discussed during the workshop, including the knowledge of pharmacogenomics towards public awareness. We are thankful to the committee members from NIH, IMR, GPD, and PMEDS who were able to attend the workshop, including taking part in the discussions. 

Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics with Assoc Prof Dr Doreen
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics
Workshop for Research & Implementation of Pharmacogenomics

Some photos took place in the NIH building, involving parties from the Precision Medicine & Scientific Wellness Association, the Institute for Medical Research (IMR), and Global Precision Diagnostics.

Recent Events